The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
Open accessAbstract
Recent studies suggest an inflammatory process, characterized by local cytokine/chemokine production and immune cell infiltration, regulates islet dysfunction and insulin resistance in type 2 diabetes. However, the factor initiating this inflammatory response is not known. Here, we characterized tissue inflammation in the type 2 diabetic GK rat with a focus on the pancreatic islet and investigated a role for IL-1. GK rat islets, previously characterized by increased macrophage infiltration, displayed increased expression of several inflammatory markers including IL-1β. In the periphery, increased expression of IL-1β was observed primarily in the liver. Specific blockade of IL-1 activity by the IL-1 receptor antagonist (IL-1Ra) reduced the release of inflammatory cytokines/chemokines from GK islets in vitro and from mouse islets exposed to metabolic stress. Islets from mice deficient in IL-1β or MyD88 challenged with glucose and palmitate in vitro also produced significantly less IL-6 and chemokines. In vivo, treatment of GK rats with IL-1Ra decreased hyperglycemia, reduced the proinsulin/insulin ratio, and improved insulin sensitivity. In addition, islet-derived proinflammatory cytokines/chemokines (IL-1β, IL-6, TNFα, KC, MCP-1, and MIP-1α) and islet CD68 + , MHC II + , and CD53 + immune cell infiltration were reduced by IL-1Ra treatment. Treated GK rats also exhibited fewer markers of inflammation in the liver. We conclude that elevated islet IL-1β activity in the GK rat promotes cytokine and chemokine expression, leading to the recruitment of innate immune cells. Rather than being directly cytotoxic, IL-1β may drive tissue inflammation that impacts on both β cell functional mass and insulin sensitivity in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D., Sauter, N. S., Ellingsgaard, H., Bosco, D., Baertschiger, R. M., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 179
Self-citationRetractedToll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 1×
“While the role of IL-1 in this response is supportive of our in vivo data, the complete dependence of this response on the signaling intermediate, MyD88, is suggestive of signaling via other IL-1 family member receptors or Toll-like receptors being involved in this islet inflammatory response (42, 43).”
BackgroundTakeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,461
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citationAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Self-citationGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
Self-citationA choice of death - the signal-transduction of immune-mediated beta-cell apoptosis
Eizirik, D. L., & Mandrup-Poulsen, T. (2001) · Diabetologia · doi:10.1007/s001250100021 · Cited by 888
The interleukin‐1 family: 10 years of discovery 1
Dinarello, C. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.15.8001745 · Cited by 783 · cited 1×
“Finally, IL-1 activity is known to increase the expression of chemokines in some tissues contributing to autoinflammatory diseases (38, 39).”
BackgroundIncreased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citationCytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
An immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394 · cited 2×
“target tissues in animal models and human type 2 diabetes ( 1-3 ).”
BackgroundThe Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1
Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373
Shafrir, E. (1984) · Medical Entomology and Zoology · Cited by 355
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Islet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D. M., Faulenbach, M., Ellingsgaard, H., Perren, A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 334
Self-citationBöni-Schnetzler, M., Thorne, J., Parnaud, G., Marselli, L., Ehses, J. A., Kerr-Conte, J., Pattou, F., Halban, P. A., Weir, G. C., & Donath, M. Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0396 · Cited by 320
Self-citationTourrel, C., Bailbe, D., Lacorne, M., Meile, M.-J., Kergoat, M., & Portha, B. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1443 · Cited by 285
Self-citationCytokines and β-Cell Biology: from Concept to Clinical Translation
Donath, M. Y., Størling, J., Berchtold, L. A., Billestrup, N., & Mandrup-Poulsen, T. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0033 · Cited by 222
Self-citationIslet Inflammation and Fibrosis in a Spontaneous Model of Type 2 Diabetes, the GK Rat
Homo-Delarche, F., Calderari, S., Irminger, J.-C., Gangnerau, M.-N., Coulaud, J., Rickenbach, K., Dolz, M., Halban, P., Portha, B., & Serradas, P. (2006) · Diabetes · doi:10.2337/db05-1526 · Cited by 213
Self-citationSauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., & Maedler, K. (2008) · Endocrinology · doi:10.1210/en.2007-1059 · Cited by 198
Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice
García, M. C., Wernstedt, I., Berndtsson, A., Enge, M., Bell, M., Hultgren, O., Horn, M., Ahrén, B., Enerback, S., Ohlsson, C., et al. (2006) · Diabetes · doi:10.2337/db05-1304 · Cited by 175
Briaud, I., Kelpe, C. L., Johnson, L. M., Tran, P. O. T., & Poitout, V. (2002) · Diabetes · doi:10.2337/diabetes.51.3.662 · Cited by 143
The GK rat beta-cell: A prototype for the diseased human beta-cell in type 2 diabetes?
Portha, B., Lacraz, G., Kergoat, M., Homo-Delarche, F., Giroix, M.-H., Bailbé, D., Gangnerau, M.-N., Dolz, M., Tourrel‐Cuzin, C., & Movassat, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.013 · Cited by 140
Self-citationPortha, B. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.566 · Cited by 130
Self-citationInterleukins and tumor necrosis factor as inhibitors of food intake
Langhans, W., & Hrupka, B. (1999) · Neuropeptides · doi:10.1054/npep.1999.0048 · Cited by 120
Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver
Bisbis, S., Bailbé, D., Tormo, M. A., Picarel-Blanchot, F., Derouet, M., Simon, J., & Portha, B. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.5.e807 · Cited by 119
Self-citationDecreased Fat Mass in Interleukin-1 Receptor Antagonist–Deficient Mice
Somm, E., Henrichot, E., Pernin, A., Juge-Aubry, C. E., Muzzin, P., Dayer, J.-M., Nicklin, M. J. H., & Meier, C. A. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3503 · Cited by 114 · cited 1×
“paradoxically develop maturity-onset obesity (28), while IL-1Ra KO mice are lean and resist HFD induced obesity ( 29 , 30).”
BackgroundExposure of human islets to cytokines can result in disproportionately elevated proinsulin release
Hostens, K., Pavlović, D., Zambre, Y., Ling, Z., Schravendijk, C. F. H. V., Eizirik, D. L., & PIPELEERS, D. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6438 · Cited by 110
Gaisano, H. Y., Östenson, C., Sheu, L., Wheeler, M. B., & Efendić, S. (2002) · Endocrinology · doi:10.1210/en.2002-220237 · Cited by 99
Portha, B., Giroix, M.-H., Serradas, P., Gangnerau, M.-N., Movassat, J., Rajas, F., Bailbé, D., Plachot, C., Mithieux, G., & Marie, J. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s89 · Cited by 93
Self-citationGiroix, M.-H., Vesco, L., & Portha, B. (1993) · Endocrinology · doi:10.1210/endo.132.2.8425496 · Cited by 83
Self-citationPicarel-Blanchot, F., Lubrano-Berthelier, C., Bailbé, D., & Portha, B. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.4.e755 · Cited by 76
Self-citationDayer-Métroz, M.-D., Wollheim, C. B., Seckinger, P., & Dayer, J. (1989) · Journal of Autoimmunity · doi:10.1016/0896-8411(89)90152-2 · Cited by 55
Movassat, J., Bailbé, D., Lubrano-Berthelier, C., Picarel-Blanchot, F., Bertin, É., Mourot, J., & Portha, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00501.2007 · Cited by 53
Self-citationWadt, K., Larsen, C. M., Andersen, H. U., Nielsen, K., Karlsen, A. E., & Mandrup-Poulsen, T. R. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1602 · Cited by 50
Warren, R. E., Zammitt, N. N., Deary, I. J., & Frier, B. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0535-6 · Cited by 43
Dachicourt, N., Bailbé, D., Gangnerau, M.-N., Serradas, P., Ravel, D., & Portha, B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00718-3 · Cited by 27
Self-citationBörjesson, A., & Carlsson, C. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.06676 · Cited by 27
Andersson, A. K., Börjesson, A., Sandgren, J., & Sandler, S. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.06.001 · Cited by 26
Chida, D., Hashimoto, O., Kuwahara, M., Sagara, H., Osaka, T., Tsubone, H., & Iwakura, Y. (2008) · Diabetologia · doi:10.1007/s00125-008-1075-z · Cited by 20
Islet Inflammation in Type 2 Diabetes (T2D): From Endothelial to β-Cell Dysfunction
Ehses, J. A., Caldérari, S., Irminger, J.-C., Serradas, P., Giroix, M.-H., Egli, A., Portha, B., Donath, M. Y., & Homo‐Delarche, F. (2007) · Current Immunology Reviews · doi:10.2174/157339507781483478 · Cited by 12
Self-citation
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Self-citationInflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Self-citationThe use of animal models in diabetes research
King, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01911.x · Cited by 1,303
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
Metadata
- Authors
- Ehses, J. A., Lacraz, G., Giroix, M.-H., Schmidlin, F., Coulaud, J., Kassis, N., Irminger, J.-C., Kergoat, M., Portha, B., Homo-Delarche, F., & Donath, M. Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-08-18
- Volume
- 106
- Issue
- 33
- Pages
- 13998-14003
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2097722989
- Cited by
- 347
- References
- 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.